Blue-blocking glasses as additive treatment for mania: A randomized placebo-controlled trial

Bipolar Disorders

Volumn 18, Issue 3, 2016, Pages 221-232

  Henriksen, Tone Eg ^a,b,c   Skrede, Silje ^a,c   Fasmer, Ole B ^a,c   Schoeyen, Helle ^a,c,d   Leskauskaite, Ieva ^e   Bjørke Bertheussen, Jeanette ^d   Assmus, Jörg ^c   Hamre, Børge ^a   Grønli, Janne ^a,f   Lund, Anders ^a,c  

^a UNIVERSITY OF BERGEN   (Norway)

^b Fonna Local Health Authority   (Norway)

^c HAUKELAND UNIVERSITY HOSPITAL   (Norway)

^d STAVANGER UNIVERSITY HOSPITAL   (Norway)

^e HAUGESUND HOSPITAL   (Norway)

^f WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

RCT; Actigraph; Activation; Bipolar disorder; Blue blockers; Chronotherapy; Dark therapy; Mania; Virtual darkness

Indexed keywords

ADULT; AGED; ARTICLE; BIPOLAR MANIA; BLUE BLOCKING GLASS; CLINICAL ARTICLE; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; DEPRESSION; FEMALE; HEADACHE; HUMAN; MALE; MOTOR ACTIVITY; NORWAY; PATIENT DROPOUT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SPECTACLES; SYMPTOM ASSESSMENT; TREATMENT OUTCOME; YOUNG MANIA RATING SCALE; ADOLESCENT; BIPOLAR DISORDER; BRAIN; CIRCADIAN RHYTHM; COLOR VISION; FEASIBILITY STUDY; HOSPITALIZATION; MIDDLE AGED; MULTIMODALITY CANCER THERAPY; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGICAL RATING SCALE; PSYCHOLOGY; PSYCHOMETRY; SIGNAL TRANSDUCTION; STATISTICS AND NUMERICAL DATA; VERTEBRATE PHOTORECEPTOR CELL; YOUNG ADULT;

TRANQUILIZER;

ADOLESCENT; ADULT; AGED; ANTIMANIC AGENTS; BIPOLAR DISORDER; BRAIN; CIRCADIAN RHYTHM; COLOR PERCEPTION; COMBINED MODALITY THERAPY; EYEGLASSES; FEASIBILITY STUDIES; FEMALE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; PHOTORECEPTOR CELLS, VERTEBRATE; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMETRICS; SIGNAL TRANSDUCTION; SINGLE-BLIND METHOD; YOUNG ADULT;

EID: 84969792523     PISSN: 13985647     EISSN: 13995618     Source Type: Journal    
DOI: 10.1111/bdi.12390     Document Type: Article

References (34)

1. Merikangas KR, Jin R, He JP et al. Prevalence and correlates of bipolar spectrum disorder in the world mental health survey initiative. Arch Gen Psychiatry 2011; 68: 241-251.
2. Cassidy F. Risk factors of attempted suicide in bipolar disorder. Suicide Life Threat Behav 2011; 41: 6-11.
3. nd edn. USA: Oxford University Press, 2007: 29-40.
4. Berk M, Dodd S, Kauer-Sant'Anna M et al. Dopamine dysregulation syndrome: implications for a dopamine hypothesis of bipolar disorder. Acta Psychiatr Scand 2007; 116: 41-49.
5. Salvadore G, Quiroz JA, Machado-Vieira R, Henter ID, Manji HK, Zarate CA Jr. The neurobiology of the switch process in bipolar disorder: a review. J Clin Psychiatry 2010; 71: 1488-1501.
6. ndedn. USA: Oxford University Press, 2007: 699-744.
7. Conus P, Berk M, Cotton SM et al. Olanzapine or chlorpromazine plus lithium in first episode psychotic mania: an 8-week randomised controlled trial. Eur Psychiatry 2015; 30: 975-982.
8. Bauer M, Glenn T, Alda M et al. Influence of light exposure during early life on the age of onset of bipolar disorder. J Psychiatr Res 2015; 64: 1-8.
9. Bauer M, Glenn T, Alda M et al. Impact of sunlight on the age of onset of bipolar disorder. Bipolar Disord 2012; 14: 654-663.
10. Geoffroy PA, Bellivier F, Scott J, Etain B. Seasonality and bipolar disorder: a systematic review, from admission rates to seasonality of symptoms. J Affect Disord 2014; 168: 210-223.
11. Dallaspezia S, Benedetti F. Chronobiology of bipolar disorder: therapeutic implication. Curr Psychiatry Rep 2015; 17: 68.
12. Arendt J. Melatonin and human rhythms. Chronobiol Int 2006; 23: 21-37.
13. Wehr TA, Turner EH, Shimada JM, Lowe CH, Barker C, Leibenluft E. Treatment of a rapidly cycling bipolar patient by using extended bed rest and darkness to stabilize the timing and duration of sleep. Biol Psychiatry 1998; 43: 822-828.
14. Wirz-Justice A, Quinto C, Cajochen C, Werth E, Hock C. A rapid-cycling bipolar patient treated with long nights, bedrest, and light. Biol Psychiatry 1999; 45: 1075-1077.
15. Barbini B, Benedetti F, Colombo C et al. Dark therapy for mania: a pilot study. Bipolar Disord 2005; 7: 98-101.
16. LeGates TA, Fernandez DC, Hattar S. Light as a central modulator of circadian rhythms, sleep and affect. Nat Rev Neurosci 2014; 15: 443-454.
17. Kayumov L, Casper RF, Hawa RJ et al. Blocking low-wavelength light prevents nocturnal melatonin suppression with no adverse effect on performance during simulated shift work. J Clin Endocrinol Metab 2005; 90: 2755-2761.
18. Sasseville A, Paquet N, Sévigny J, Hébert M. Blue blocker glasses impede the capacity of bright light to suppress melatonin production. J Pineal Res 2006; 41: 73-78.
19. van de Werken M, Giménez MC, de Vries B, Beersma DG, Gordijn MC. Short-wavelength attenuated polychromatic white light during work at night: limited melatonin suppression without substantial decline of alertness. Chronobiol Int 2013; 30: 843-854.
20. Phelps J. Dark therapy for bipolar disorder using amber lenses for blue light blockade. Med Hypotheses 2008; 70: 224-229.
21. Gomez-Bernal G. Dark therapy for schizoaffective disorder. A case report. Med Hypotheses 2009; 72: 105-106.
22. Henriksen TE, Skrede S, Fasmer OB, Hamre B, Grønli J, Lund A. Blocking blue light during mania - markedly increased regularity of sleep and rapid improvement of symptoms: a case report. Bipolar Disord 2014; 16: 894-898.
23. Bromundt V. Störungen des Schlaf-Wach-Rhythmus bei psychiatrischen Erkrankungen. Ther Umsch 2014; 71: 663-670.
24. th edn. Washington DC: APA, 2000.
25. Sheehan DV, Lecrubier Y, Sheehan KH et al. The Mini-International Neuropsychiatric Interview (MINI): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry 1998; 59: 22-33.
26. Young R, Biggs J, Ziegler V, Meyer D. A rating scale for mania: reliability, validity and sensitivity. Br J Psychiatry 1978; 133: 429-435.
27. Krane-Gartiser K, Henriksen TE, Morken G, Vaaler A, Fasmer OB. Actigraphic assessment of motor activity in acutely admitted inpatients with bipolar disorder. PLoS One 2014; 9: e89574.
28. Vandewalle G, Maquet P, Dijk D-J. Light as a modulator of cognitive brain function. Trends Cogn Sci 2009; 13: 429-438.
29. Vandewalle G, Schmidt C, Albouy G et al. Brain responses to violet, blue, and green monochromatic light exposures in humans: prominent role of blue light and the brainstem. PLoS One 2007; 2: e1247.
30. Benarroch EE. The locus ceruleus norepinephrine system: functional organization and potential clinical significance. Neurology 2009; 73: 1699-1704.
31. Daban C, Vieta E, Mackin P, Young AH. Hypothalamic-pituitary-adrenal axis and bipolar disorder. Psychiatr Clin N Am 2005; 28: 469-480.
32. Vandewalle G, Archer SN, Wuillaume C et al. Effects of light on cognitive brain responses depend on circadian phase and sleep homeostasis. J Biol Rhythms 2011; 26: 249-259.
33. Davis JM. Theories of Biological etiology of affective disorders. Int Rev Neurobiol 1970; 12: 145-175.
34. van der Lely S, Frey S, Garbazza C et al. Blue blocker glasses as a countermeasure for alerting effects of evening light-emitting diode screen exposure in male teenagers. J Adolesc Health 2015; 56: 113-119.